Motus GI Holdings, which is developing a medical device to assist with intraprocedural colonoscopy cleaning, raised $18 million by offering 3.5 million shares at $5, the low end of the range of $5 to $7. At pricing, the company commands a fully diluted market value of $79 million. Existing shareholders purchased $7.5 million (43% of deal size) on the IPO. Motus GI Holdings plans to list on the Nasdaq under the symbol MOTS. Piper Jaffray and Oppenheimer & Co. acted as lead managers on the deal.
